CODEXIS (CDXS) director receives 66,350 stock options at $2.48 strike price

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CODEXIS, INC. director Christos Richards received a grant of stock options covering 66,350 shares of common stock at an exercise price of $2.48 per share. The options were awarded at no cost, vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to his continued board service, and will expire on June 17, 2036.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Richards Christos

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	66,350	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 66,350 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 66,350 shares Exercise price: $2.48 per share Total options after grant: 66,350 options +1 more

4 metrics

Option grant size 66,350 shares Underlying common stock in new option award

Exercise price $2.48 per share Stock option conversion or exercise price

Total options after grant 66,350 options Total derivative securities following transaction

Expiration date June 17, 2036 Option expiration for the grant

Key Terms

Stock Option (Right to Buy), grant/award acquisition, exercise price, expiration date, +2 more

6 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

exercise price financial

"conversion_or_exercise_price: "2.4800""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-06-17T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vests and becomes exercisable financial

"This option vests and becomes exercisable with respect to all of the shares"

annual stockholder meeting financial

"on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting"

An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/18/2026 - 04:56 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Richards Christos

(Last)

(First)

(Middle)

C/O CODEXIS, INC.

200 PENOBSCOT DRIVE

(Street)

REDWOOD CITY

CALIFORNIA

94063

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$2.48	06/17/2026		A		66,350		⁽¹⁾	06/17/2036	Common Stock	66,350	$0	66,350	D

Explanation of Responses:

1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.

	/s/ Georgia Erbez, as Attorney-in-Fact for Christos Richards	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did CODEXIS (CDXS) director Christos Richards report in this Form 4?

Christos Richards reported receiving a grant of stock options for 66,350 shares of CODEXIS common stock. These options were granted at no cost and give him the right to buy shares at a fixed $2.48 exercise price before they expire in June 2036.

How many CODEXIS (CDXS) shares are covered by the new stock options?

The new stock option grant covers 66,350 underlying shares of CODEXIS common stock. This entire amount was acquired in a single award and represents his total option holdings reported following the transaction, according to the Form 4 transaction detail.

What is the exercise price and expiration date of the CODEXIS (CDXS) options?

The options have an exercise price of $2.48 per share and expire on June 17, 2036. This means Richards can choose to buy CODEXIS common stock at $2.48 any time after vesting and before the June 17, 2036 expiration date.

When do Christos Richards’ CODEXIS (CDXS) stock options vest?

The options vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting. Vesting is conditioned on Richards’ continued service as a director on that vesting date, as described in the Form 4 footnote.

Did Christos Richards buy or sell any CODEXIS (CDXS) shares in the market?

The Form 4 reports a grant of stock options classified as an acquisition, not an open‑market trade. The transaction code is “A” for grant or award, and no separate buy or sell transactions in common stock are shown in the provided data.

Is the new CODEXIS (CDXS) option grant held directly by Christos Richards?

Yes. The Form 4 lists the ownership type as direct with an ownership code of “D.” There is no footnote indicating that the options are held through a trust, partnership, or other indirect entity on his behalf.